Congenital Adrenal Hyperplasia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia
Conditions: Congenital Adrenal Hyperplasia; CAH - Congenital Adrenal Hyperplasia; CAH - 21-Hydroxylase Deficiency Intervention: Drug: SPR001 Sponsor: Spruce Biosciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2018 Category: Research Source Type: clinical trials
LC-MS / MS Adrenal Steroids Assayed on Dried Blot Spot for the Congenital Adrenal Hyperplasia Neonatal Screening (SPECTROSPOT)
Condition: Adrenal Hyperplasia, Congenital Intervention: Sponsor: Assistance Publique - Hôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 17, 2018 Category: Research Source Type: clinical trials